Examination of the interaction between peripheral diclofenac and gabapentin on the 5% formalin test in rats

Life Sciences

Volumn 79, Issue 24, 2006, Pages 2283-2287

  Picazo, Alejandra ^a   Castañeda Hernández, Gilberto ^a   Ortiz, Mario I ^b  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DEL ESTADO DE HIDALGO   (Mexico)

Author keywords

Antinociception; Diclofenac; Formalin test; Gabapentin; Synergism

Indexed keywords

DICLOFENAC; FORMALDEHYDE; GABAPENTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENCY; DRUG SCREENING; FEMALE; NONHUMAN; RAT;

AMINES; ANALGESICS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOHEXANECARBOXYLIC ACIDS; DICLOFENAC; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; DRUG SYNERGISM; FEMALE; FORMALDEHYDE; GAMMA-AMINOBUTYRIC ACID; HINDLIMB; PAIN MEASUREMENT; RATS; RATS, WISTAR;

EID: 33751088562     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2006.07.025     Document Type: Article

References (34)

1. Alves D.P., Tatsuo M.A., Leite R., and Duarte I.D. Diclofenac-induced peripheral antinociception is associated with ATP-sensitive K+ channels activation. Life Sciences 74 (2004) 2577-2591
2. Aubrun F., Langeron O., Quesnel C., Coriat P., and Riou B. Relationships between measurement of pain using visual analog score and morphine requirements during postoperative intravenous morphine titration. Anesthesiology 98 (2003) 1415-1421
3. Baillie J.K., and Power J. The mechanisms of action of gabapentin in neuropathic pain. Current Opinion in Investigational Drugs 7 (2006) 33-39
4. Carlton S.M., and Zhou S. Attenuation of formalin-induced nociceptive behaviors following local peripheral injection of gabapentin. Pain 76 (1998) 201-207
5. Castañeda-Hernández G., Granados-Soto V., and Ortiz M.I. Pinacidil increases diclofenac antinociception in the formalin test. Proceedings of the Western Pharmacology Society 48 (2005) 55-58
6. Curatolo M., and Sveticic G. Drug combinations in pain treatment: a review of the published evidence and a method for finding the optimal combination. Best practice and research. Clinical Anaesthesiology 16 (2002) 507-519
7. Czuczwar M., Kis J., Luszczki J., Turski W.A., and Przesmycki K. Evaluation of interaction between gabapentin and baclofen in the formalin test in mice. Polish Journal of Pharmacology 55 (2003) 803-806
8. Field M.J., Oles R.J., Lewis A.S., McCleary S., Huges J., and Singh L. Gabapentin (neurontin) and S-(+)-3-isobutyl GABA represent a novel class of selective antihyperalgesic agents. British Journal of Pharmacology 121 (1997) 1513-1522
9. Fletcher D., Benoist J.M., Gautron M., and Guilbaud G. Isobolographic analysis of interactions between intravenous morphine, propacetamol, and diclofenac in carrageenin-injected rats. Anesthesiology 87 (1997) 317-326
10. Granados-Soto V., and Arguelles C.F. Synergic antinociceptive interaction between tramadol and gabapentin after local, spinal and systemic administration. Pharmacology 74 (2005) 200-208
11. Granados-Soto V., Rufino M.O., Gomes Lopes L.D., and Ferreira S.H. Evidence for the involvement of the nitric oxide-cGMP pathway in the antinociception of morphine in the formalin test. European Journal of Pharmacology 340 (1997) 177-180
12. Harden R.N. Chronic neuropathic pain. Mechanisms, diagnosis, and treatment. The Neurologist 11 (2005) 111-122
13. Hurley R.W., Chatterjea D., Rose Feng M., Taylor C.P., and Hammond D.L. Gabapentin and pregabalin can interact synergistically with naproxen to produce antihyperalgesia. Anesthesiology 97 (2002) 1263-1273
14. Jensen M.P., Chen C., and Brugger A.M. Interpretation of visual analog scale ratings and change scores: a reanalysis of two clinical trials of postoperative pain. The Journal of Pain 4 (2003) 407-414
15. Jiménez-Andrade J.M., Ortiz M.I., Pérez-Urizar J., Aguirre-Bañuelos P., Granados-Soto V., and Castañeda-Hernández G. Synergistic effects between codeine and diclofenac after local, spinal and systemic administration. Pharmacology, Biochemistry and Behavior 76 (2003) 463-471
16. + channel pathway in the antinociceptive action of ketorolac. European Journal of Pharmacology 426 (2001) 39-44
17. Li Wan Po A., and Zhang W.Y. Systematic overview of co-proxamol to assess analgesic effects of addition of dextropropoxyphene to paracetamol. British Medical Journal 315 (1997) 1565-1571
18. Litkowski L.J., Christensen S.E., Adamson D.N., Van Dyke T., Han S.H., and Newman K.B. Analgesic efficacy and tolerability of oxycodone 5 mg/ibuprofen 400 mg compared with those of oxycodone 5 mg/acetaminophen 325 mg and hydrocodone 7.5 mg/acetaminophen 500 mg in patients with moderate to severe postoperative pain: a randomized, double-blind, placebo-controlled, single-dose, parallel-group study in a dental pain model. Clinical Therapeutics 27 (2005) 418-429
19. López-Muñoz F.J., Castañeda-Hernández G., Villalón C.M., Terrón J.A., and Salazar L.A. Analgesic effects of combinations containing opioid drugs with either aspirin or acetaminophen in the rat. Drug Development Research 29 (1993) 299-304
20. Ortega-Varela L.F., Herrera J.E., Medina-Santillán R., Reyes-García G., Rocha-González H.I., and Granados-Soto V. Synergistic interaction between gabapentin and metamizol in the rat formalin test. Proceedings of the Western Pharmacology Society 47 (2004) 80-83
21. Ortiz M.I., Granados-Soto V., and Castañeda-Hernández G. The NO-cGMP-K(+) channel pathway participates in the antinociceptive effect of diclofenac, but not of indomethacin. Pharmacology, Biochemistry and Behavior 76 (2003) 187-195
22. Ortiz M.I., Castañeda-Hernández G., and Granados-Soto V. Pharmacological evidence for the activation of Ca2+-activated K+ channels by meloxicam in the formalin test. Pharmacology, Biochemistry and Behavior 81 (2005) 725-731
23. + channels pathway by codeine. Pharmacology, Biochemistry and Behavior 82 (2005) 695-703
24. Ortiz M.I., Medina-Tato D.A., Sarmiento-Heredia D., Palma-Martínez J., and Granados-Soto V. Possible activation of the NO-cyclic GMP-protein kinase G-K(+) channels pathway by gabapentin on the formalin test. Pharmacology, Biochemistry and Behavior 83 (2006) 420-427
25. Strobel E. Drug therapy in severe tumor pain. Comparative study of a new combination preparation versus diclofenac-Na. Fortschritte der Medizin 110 (1992) 411-414
26. Tallarida R.J. Drug Synergism and Dose-Effect Data Analysis. 1st. Ed. (2000), Chapman & Hall/CRC, New York 1-72
27. Tallarida R.J. The interaction index: a measure of drug synergism. Pain 98 (2002) 163-168
28. Tallarida R.J., Stone D.J., McCarty J.D., and Raffa R.B. Response surface analysis of synergism between morphine and clonidine. The Journal of Pharmacology and Experimental Therapeutics 289 (1999) 8-13
29. Todorovic S.M., Rastogi A.J., and Jevtovic-Todorovic V. Potent analgesic effects of anticonvulsants on peripheral thermal nociception in rats. British Journal of Pharmacology 140 (2003) 255-260
30. Vane J.R., and Botting R.M. Mechanism of action of anti-inflammatory drugs. Scandinavian Journal of Rheumatology 102 (1996) 9-21
31. Voilley N., De Weille J., Mamet J., and Lazdunski M. Nonsteroid anti-inflammatory drugs inhibit both the activity and the inflammation-induced expression of acid-sensing ion channels in nociceptors. The Journal of Neuroscience 21 (2001) 8026-8033
32. Yoon M.H., and Yaksh T.L. Evaluation of interaction between gabapentin and ibuprofen on the formalin test in rats. Anesthesiology 91 (1999) 1006-1013
33. Yoon M.H., Bae H.B., and Choi J.I. Antinociceptive interactions between intrathecal gabapentin and MK801 or NBQX in rat formalin test. Journal of Korean Medical Science 20 (2005) 307-312
34. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16 (1983) 109-110